Results 181 to 190 of about 2,929,870 (356)
Study on the Traffic Congestion Control Based on Big Data Rule Collecting [PDF]
Bo Gao
openalex +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Protective structural and enzymatic roles of catechin and gallic acid against nephrotoxicity and hepatotoxicity ınduced by cisplatin. [PDF]
Kalkan NS, Gökçimen A.
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Successful multidisciplinary management of pregnancy in a woman with glycogen storage disease type IIIA. [PDF]
Shakerdi LA +8 more
europepmc +1 more source
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
A rare case of pancreatitis caused by pancreas divisum in a middle-aged patient and treated with stent implantation: Case report. [PDF]
Altwer NAA, Alsaid B.
europepmc +1 more source
Collecting Societies Codes of Conduct: Executive Summary
Benedict Atkinson, Brian Fitzgerald
openalex +1 more source

